| BioVision |
1814-025 |
Leptomycin B
|
25 µg |
|
|
| BioVision |
1812-25 |
GANT58
|
25 mg |
|
|
| BioVision |
1812-5 |
GANT58
|
5 mg |
|
|
| BioVision |
1811-5 |
IKK-ε Kinase Inhibitor II
|
5 mg |
|
|
| BioVision |
1805-1000 |
Lestaurtinib
|
1 mg |
|
|
| BioVision |
1809-25 |
WP1066
|
25 mg |
|
|
| BioVision |
1809-5 |
WP1066
|
5 mg |
|
|
| BioVision |
1808-250 |
Monensin Methyl Ester
|
250 mg |
|
|
| BioVision |
1802-100G |
Imidazole, MegaPure™
|
100 g |
|
|
| BioVision |
1803-25 |
EZSolution™ Tozasertib
|
25 mg |
|
|
| BioVision |
1808-50 |
Monensin Methyl Ester
|
50 mg |
|
|
| BioVision |
1801-25 |
VO-OHpic, Trihydrate
|
25 mg |
|
|
| BioVision |
1805-500 |
Lestaurtinib
|
500 µg |
|
|
| BioVision |
1804-25 |
EZSolution™ Sunitinib Malate
|
25 mg |
|
|
| BioVision |
1800-25 |
AG 1478
|
25 mg |
|
|
| BioVision |
1801-5 |
VO-OHpic, Trihydrate
|
5 mg |
|
|
| BioVision |
1802-25G |
Imidazole, MegaPure™
|
25 g |
|
|
| BioVision |
1797-50 |
PP3
|
50 mg |
|
|
| BioVision |
1798-100 |
2-APB
|
100 mg |
|
|
| BioVision |
1799-1 |
GM 6001
|
1 mg |
|
|
| BioVision |
1796-5 |
Bay 61-3606 Hydrochloride
|
5 mg |
|
|
| BioVision |
1800-5 |
AG 1478
|
5 mg |
|
|
| BioVision |
1792-25 |
LLL12
|
25 mg |
|
|
| BioVision |
1797-10 |
PP3
|
10 mg |
|
|
| BioVision |
1796-1 |
Bay 61-3606 Hydrochloride
|
1 mg |
|
|
| BioVision |
1794-5 |
bpV(pic)
|
5 mg |
|
|
| BioVision |
1793-5 |
bpV(phen)
|
5 mg |
|
|
| BioVision |
1790-5 |
Marimastat
|
5 mg |
|
|
| BioVision |
1792-5 |
LLL12
|
5 mg |
|
|
| BioVision |
1789-5 |
ZM 336372
|
5 mg |
|
|
| BioVision |
1791-5 |
EZSolution™ MG-132
|
5 mg |
|
|
| BioVision |
1787-50 |
Fasudil, Monohydrochloride
|
50 mg |
|
|
| BioVision |
1790-1 |
Marimastat
|
1 mg |
|
|
| BioVision |
1786-1 |
EZSolution™ SB 203580
|
1 mg |
|
|
| BioVision |
1787-10 |
Fasudil, Monohydrochloride
|
10 mg |
|
|
| BioVision |
1789-1 |
ZM 336372
|
1 mg |
|
|
| BioVision |
1782-100G |
Octyl-β-D-thioglucopyranoside
|
100 g |
|
|
| BioVision |
1783-5 |
EZSolution™ PD 98059
|
5 mg |
|
|
| BioVision |
1784-5 |
EZSolution™ Y-27632
|
5 mg |
|
|
| BioVision |
1781-1 |
TGX-221
|
1 mg |
|
|
| BioVision |
1781-5 |
TGX-221
|
5 mg |
|
|
| BioVision |
1785-500 |
EZSolution™ Gö 6976
|
500 µg |
|
|
| BioVision |
1782-50G |
Octyl-β-D-thioglucopyranoside
|
50 g |
|
|
| BioVision |
1782-5G |
Octyl-β-D-thioglucopyranoside
|
5 g |
|
|
| BioVision |
1782-1G |
Octyl-β-D-thioglucopyranoside
|
1 g |
|
|
| BioVision |
1780-5 |
PI3-Kɣ Inhibitor, AS-605240
|
5 mg |
|
|
| BioVision |
1780-1 |
PI3-Kɣ Inhibitor, AS-605240
|
1 mg |
|
|
| BioVision |
1777-5G |
Sulfobetaine 3-16
|
5 g |
|
|
| BioVision |
1777-25G |
Sulfobetaine 3-16
|
25 g |
|
|
| BioVision |
1778-1 |
Stat3 Peptide Inhibitor, Cell-Permeable
|
1 mg |
|
|